Tuesday, February 26, 2013

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period

"Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period"





Dr. Zoe MariƱo discusses her article "Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period"

Abstract - http://www.journal-of-hepatology.eu/article/S0168-8278(12)00768-4/abstract

Editorial - Silibinin: An old drug in the high tech era of liver transplantation

No comments:

Post a Comment